Patients with Venous Thromboembolism After Spontaneous Intracerebral Hemorrhage: a Review

Overview

Journal Thromb J

Publisher Biomed Central

Date 2021 Nov 28

PMID 34838069

Citations 9

Authors

Qiyan Cai

Xin Zhang

Hong Chen

Affiliations

Soon will be listed here.

Abstract

Background: Patients with spontaneous intracerebral hemorrhage (ICH) have a higher risk of venous thromboembolism (VTE) and in-hospital VTE is independently associated with poor outcomes for this patient population.

Methods: A comprehensive literature search about patients with VTE after spontaneous ICH was conducted using databases MEDLINE and PubMed. We searched for the following terms and other related terms (in US and UK spelling) to identify relevant studies: intracerebral hemorrhage, ICH, intraparenchymal hemorrhage, IPH, venous thromboembolism, VTE, deep vein thrombosis, DVT, pulmonary embolism, and PE. The search was restricted to human subjects and limited to articles published in English. Abstracts were screened and data from potentially relevant articles was analyzed.

Results: The prophylaxis and treatment of VTE are of vital importance for patients with spontaneous ICH. Prophylaxis measures can be mainly categorized into mechanical prophylaxis and chemoprophylaxis. Treatment strategies include anticoagulation, vena cava filter, systemic thrombolytic therapy, catheter-based thrombus removal, and surgical embolectomy. We briefly summarized the state of knowledge regarding the prophylaxis measures and treatment strategies of VTE after spontaneous ICH in this review, especially on chemoprophylaxis and anticoagulation therapy. Early mechanical prophylaxis, especially with intermittent pneumatic compression, is recommended by recent guidelines for patients with spontaneous ICH. While decision-making on chemoprophylaxis and anticoagulation therapy evokes debate among clinicians, because of the concern that anticoagulants may increase the risk of recurrent ICH and hematoma expansion. Uncertainty still exists regarding optimal anticoagulants, the timing of initiation, and dosage.

Conclusion: Based on current evidence, we deem that initiating chemoprophylaxis with UFH/LMWH within 24-48 h of ICH onset could be safe; anticoagulation therapy should depend on individual clinical condition; the role of NOACs in this patient population could be promising.

Citing Articles

Elevated basophils in peripheral blood predict lower extremity deep venous thrombosis in non-surgical patients with spontaneous intracerebral hemorrhage.

Liu C, Wu B, Luo L, Wang J, Hu W, Zhang X Sci Rep. 2025; 15(1):7397.

PMID: 40032934 PMC: 11876693. DOI: 10.1038/s41598-025-91851-x.

Development of a Predictive Nomogram Model for Early Deep Vein Thrombosis in Postoperative Spontaneous Intracerebral Hemorrhage Patients.

Tang L, Xu Y, Wang L, Pan J, Wu Y Int J Gen Med. 2024; 17:4793-4803.

PMID: 39440100 PMC: 11495207. DOI: 10.2147/IJGM.S484611.

Effect of heparin for the prevention of venous thromboembolism in patients with spontaneous intracranial cerebral hemorrhage: a meta-analysis.

Zhou Y, Wang G, Xue C, He G, Zhang Y, He F Ther Adv Drug Saf. 2024; 15:20420986241253469.

PMID: 38784386 PMC: 11113067. DOI: 10.1177/20420986241253469.

Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance.

Zhang R, Sun W, Xing Y, Wang Y, Li Z, Liu L Thromb J. 2024; 22(1):22.

PMID: 38419108 PMC: 10900581. DOI: 10.1186/s12959-024-00592-w.

Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients.

Imbalzano E, Orlando L, Dattilo G, De Fazio M, Camporese G, Russo V Medicina (Kaunas). 2024; 60(1).

PMID: 38256416 PMC: 11154512. DOI: 10.3390/medicina60010156.

References

Schulman S, Kearon C, Kakkar A, Mismetti P, Schellong S, Eriksson H . Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009; 361(24):2342-52. DOI: 10.1056/NEJMoa0906598. View

Arakawa S, Saku Y, Ibayashi S, Nagao T, Fujishima M . Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke. 1998; 29(9):1806-9. DOI: 10.1161/01.str.29.9.1806. View

Hagii J, Tomita H, Metoki N, Saito S, Shiroto H, Hitomi H . Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin. Stroke. 2014; 45(9):2805-7. DOI: 10.1161/STROKEAHA.114.006661. View

Ianosi B, Gaasch M, Rass V, Huber L, Hackl W, Kofler M . Early thrombosis prophylaxis with enoxaparin is not associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage. Eur J Neurol. 2018; 26(2):333-341. DOI: 10.1111/ene.13830. View

Pollack Jr C, Reilly P, van Ryn J, Eikelboom J, Glund S, Bernstein R . Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med. 2017; 377(5):431-441. DOI: 10.1056/NEJMoa1707278. View

Li L, Poon M, Samarasekera N, Perry L, Moullaali T, Rodrigues M . Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies. Lancet Neurol. 2021; 20(6):437-447. PMC: 8134058. DOI: 10.1016/S1474-4422(21)00075-2. View

Ajmeri A, Zaheer K, McCorkle C, Amro A, Mustafa B . Treating Venous Thromboembolism Post Intracranial Hemorrhage: A Case Report. Cureus. 2020; 12(1):e6746. PMC: 7034755. DOI: 10.7759/cureus.6746. View

Ogata T, Yasaka M, Wakugawa Y, Inoue T, Ibayashi S, Okada Y . Deep venous thrombosis after acute intracerebral hemorrhage. J Neurol Sci. 2008; 272(1-2):83-6. DOI: 10.1016/j.jns.2008.04.032. View

Goldstein J, Fazen L, Wendell L, Chang Y, Rost N, Snider R . Risk of thromboembolism following acute intracerebral hemorrhage. Neurocrit Care. 2008; 10(1):28-34. PMC: 4307935. DOI: 10.1007/s12028-008-9134-3. View

10.

Sochart D, Hardinge K . The relationship of foot and ankle movements to venous return in the lower limb. J Bone Joint Surg Br. 1999; 81(4):700-4. DOI: 10.1302/0301-620x.81b4.8909. View

11.

Wada R, Aviv R, Fox A, Sahlas D, Gladstone D, Tomlinson G . CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007; 38(4):1257-62. DOI: 10.1161/01.STR.0000259633.59404.f3. View

12.

Cheng X, Zhang L, Xie N, Ma Y, Lian Y . High Plasma Levels of D-Dimer Are Independently Associated with a Heightened Risk of Deep Vein Thrombosis in Patients with Intracerebral Hemorrhage. Mol Neurobiol. 2015; 53(8):5671-8. DOI: 10.1007/s12035-015-9487-5. View

13.

Carney B, Uhlmann E, Puligandla M, Mantia C, Weber G, Neuberg D . Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism. Res Pract Thromb Haemost. 2020; 4(5):860-865. PMC: 7354400. DOI: 10.1002/rth2.12377. View

14.

Pottier P, Hardouin J, Lejeune S, Jolliet P, Gillet B, Planchon B . Immobilization and the risk of venous thromboembolism. A meta-analysis on epidemiological studies. Thromb Res. 2009; 124(4):468-76. DOI: 10.1016/j.thromres.2009.05.006. View

15.

Di Nisio M, van Es N, Buller H . Deep vein thrombosis and pulmonary embolism. Lancet. 2016; 388(10063):3060-3073. DOI: 10.1016/S0140-6736(16)30514-1. View

16.

Orken D, Kenangil G, Ozkurt H, Guner C, Gundogdu L, Basak M . Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist. 2009; 15(6):329-31. DOI: 10.1097/NRL.0b013e3181a93bac. View

17.

Lee W, Fang H . Management of pulmonary embolism after recent intracranial hemorrhage: A case report. Medicine (Baltimore). 2018; 97(15):e0479. PMC: 5908629. DOI: 10.1097/MD.0000000000010479. View

18.

Hansmann J, Sheybani A, Minocha J, Bui J, Lipnik A, Shah K . Retrievable inferior vena cava filters in neurosurgical patients: Retrieval rates and clinical outcomes. Clin Neurol Neurosurg. 2019; 179:30-34. DOI: 10.1016/j.clineuro.2019.02.016. View

19.

Mellado M, Trujillo-Santos J, Bikdeli B, Jimenez D, Jesus Nunez M, Ellis M . Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism. Intern Emerg Med. 2019; 14(7):1101-1112. DOI: 10.1007/s11739-019-02077-5. View

20.

Flibotte J, Hagan N, ODonnell J, Greenberg S, Rosand J . Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004; 63(6):1059-64. DOI: 10.1212/01.wnl.0000138428.40673.83. View